Overview
Otsuka Holdings is the Tokyo holding company of a group whose segments are Pharmaceuticals, Nutraceuticals, Consumer Products and Others.[2] The pharmaceuticals segment makes therapeutic drugs and infusions focused on the central nervous system, oncology and infectious diseases, while nutraceuticals include nutritional foods, health drinks and supplements, and consumer products include mineral water and beverages.[2] Forbes records sales of US$16.7bn, up 8.6%, and profit of US$2.5bn, a margin of 15%.[2] The holding company was formed on 8 July 2008, according to Forbes, which counts 37,758 employees.[2] Otsuka is the second-largest Japanese company in this ranking, ahead of Astellas and Daiichi Sankyo, though behind Takeda.
Otsuka Holdings strengths and limitations
Strengths
- Diversified into nutrition and consumer products
- Profit margin of 15%
- Sales growth of 8.6%
Limitations
- Non-pharma revenue included in total
- Results translated from yen
- Smaller global footprint than the leaders
Appears in
Otsuka Holdings peers and competitors
Companies ranked in the same lists as Otsuka Holdings.
Johnson & Johnson- Amgen
Daiichi Sankyo- Astellas Pharma
Viatris- Regeneron Pharmaceuticals
- CSL
- Teva Pharmaceutical
Merck KGaA
Gilead Sciences
Takeda Pharmaceutical
GSK plc
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.